Clinical trial

HTA of NIVATS Based on RWE

NCT06574295

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2024-08-20

PhaseN/A

Study timeline

Study start (actual)2024-08-20Date precision: day

Registry last updated2026-09-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

Sponsors & collaborators

Fudan Universitylead sponsor

Mapped research locations

WuhanHubei, China2 ShanghaiShanghai Municipality, China1 GuangzhouGuangdong, China1 NanjingJiangsu, China1 JinanShandong, China1 ChongqingChongqing Municipality, China1 HefeiAnhui, China1 FuzhouFujian, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06574295 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.